Company / Book Value per Share
Cullinan Therapeutics, Inc. Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$10.089
FY2024
5-year range
$10.073 / $14.246
FY2020-FY2024
Trend
-7.6%
vs FY2023
Sector context
#55 of 209
Health Care
What the data says
At $10.089, Cullinan Therapeutics, Inc.'s book value per share ranks #55 of 209 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $14.246 in FY2021 to $10.089 in FY2024.
Based on SEC 10-K filings.
$10.089 in FY2024 with a 3-year CAGR of -10.9%.
Declined from $11.683 to $10.089 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 209 in Health CareTop 26% of 209This company $10.089 Sector average $189.429
▼
-94.7% below sector average
Key checks
Key Insights
- Cullinan Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -10.9%, indicating a declining trend.
- In FY2024, book value per share decreased 7.6% year-over-year.
- Ranks #55 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.089 | -7.6% |
| FY2023 | $10.919 | -6.5% |
| FY2022 | $11.683 | -18.0% |
| FY2021 | $14.246 | +41.4% |
| FY2020 | $10.073 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026